Skip to main content

Table 1 Demographic and clinical characteristics of study participants

From: Nomogram to predict multidrug-resistant tuberculosis

Characteristic

TB patient

P-value

MDR-TB (n = 213)

DS-TB (n = 487)

Gender, n (%)

  

0.962

 Male

84 (39.4)

193 (39.6)

 

 Female

129 (60.6)

294 (60.4)

 

Alcohol use (≥ one unit/day), n (%)

  

0.606

 Yes

26 (12.2)

53 (10.9)

 

 No

187 (87.8)

434 (89.1)

 

Smoking (any cigarettes/week), n (%)

  

0.256

 Yes

38 (17.8)

70 (14.4)

 

 No

175 (82.2)

417 (85.6)

 

Previous TB history, n (%)

  

<0.001

 Yes

68 (31.9)

62 (12.9)

 

 No

145 (68.1)

425 (87.1)

 

HIV positive, n (%)

  

0.020

 Yes

18 (8.5)

20 (4.1)

 

 No

195 (91.5)

467 (95.9)

 

Coexisting diabetes, n (%)

  

0.518

 Yes

14 (6.6)

26 (5.3)

 

 No

199 (93.4)

461 (94.7)

 

History of hospitalization, n (%)

  

0.257

 Yes

14 (6.6)

22 (4.5)

 

 No

199 (93.4)

465 (95.5)

 

Any side effects of treatment, n (%)

  

<0.001

 Yes

145 (68.1)

206 (42.3)

 

 No

68 (31.9)

281 (57.7)

 

Socioeconomic statusa, n (%)

 

0.152

 1

77 (36.2)

211 (43.3)

 

 2

73 (34.3)

137 (28.1)

 

 3

63 (29.6)

139 (28.5)

 

Completed secondary education, n (%)

  

0.007

 Yes

143 (67.1)

274 (56.9)

 

 No

70 (32.9)

213 (43.1)

 

Employment status, n (%)

 

0.114

 Unemployed

131 (61.5)

247 (50.7)

 

 Working

60 (28.2)

175 (35.9)

 

 Student

22 (10.3)

62 (12.7)

 

 Unknown

0 (0.0)

3 (0.1)

 

Spoligotype family (SpolDB4 Database), n (%)

 

<0.001

 Haarlem

23 (10.8)

120 (24.6)

 

 Beijing

19 (8.9)

53 (10.9)

 

 Latin American Mediterranean

42 (19.7)

50 (10.3)

 

 T

76 (35.7)

67 (13.8)

 

 Other Euro-Americanb

10 (4.7)

51 (10.5)

 

 Orphan/no family

17 (8.0)

58 (11.9)

 

 Unknown (no data)

26 (12.2)

88 (18.1)

 

Sputum smear grade, n (%)

 

0.100

 0

26 (12.2)

41 (8.4)

 

 1

52 (24.4)

145 (29.8)

 

 2

47 (22.1)

133 (27.3)

 

 3

82 (38.5)

152 (31.2)

 

Unknown

6 (2.8)

16 (3.3)

 

Mean cough duration, (weeks)

4.0 (2.2–8.0)

4.0 (2.0–8.0)

0.112

  1. TB tuberculosis, HIV human immunodeficiency virus, MDR-TB multidrug-resistant tuberculosis, DS-TB drug-susceptible tuberculosis
  2. aDivided into three levels based on the scoring system used in the Peruvian National Census
  3. b “Other Euro-American” includes strains from the S family, the X family, and strains that were present in the SpolDB4 Database but had not yet been assigned a family [9]